Endocrine system - University of Babylon

Anti-resorptive agents including bisphosphonates, estrogen, SERMs and Amgen's Prolia are the most common treatments for osteoporosis. Teriparatide, marketed by Lilly under the name Forteo/Forsteo (outside the U.S.), is the only other anabolic drug targeting the PTH receptor approved in the United States for the treatment of osteoporosis. ................
................